Goodwin Procter represented Candel Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Candel Therapeutics, Inc. (Nasdaq: CDL) announced the...
Candel Therapeutics’ $92 Million Common Stock Offering
BiomX’s Merger with Adaptive Phage Therapeutics
Haynes and Boone is advising BiomX Inc. on the transaction, Cooley is advising Adaptive Phage Therapeutics and Wilmer Cutler Pickering Hale and Dorr is advising the...